EUVIMEDEUVIMED entdecken
Open Access

Combined Transcranial Sonography of the Substantia Nigra and 18 F‐Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Parkinson's Disease and Atypical Parkinsonian Syndromes

Tong Wu, Ziwei Zhou, Wenjie Gong, Jinju Sun, Weicheng Zhou, Xin Li, Jingqin Fang iD, Xiao Chen iD

Movement Disorders Clinical Practice · 2026-11 · 13 (11) · 2812-2821

DOI: 10.1002/mdc3.70769 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders Clinical Practice, online erschienen am 09.08.2026. Verfasst von Tong Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Daping Hospital, Army Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Substantia Nigra, Positron Emission Tomography Computed Tomography, Ultrasonography, Doppler, Transcranial, Parkinsonian Disorders. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: AI Medical Research Project of Army Medical Center, Natural Science Foundation of Chongqing, Chongqing Science and Health Joint Medical Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Accurate differentiation between Parkinson's disease (PD) and atypical parkinsonian syndromes (APS) remains challenging where dual‐tracer ( 11 C‐2β‐carbomethoxy‐3β‐(4‐fluorophenyl) tropane [[ 11 C]CFT] and 18 F‐fluorodeoxyglucose [[ 18 F]FDG]) positron emission tomography/computed tomography (PET/CT) access is limited.

Objective

The aim was to investigate whether transcranial sonography (TCS) of the substantia nigra (SN) can replace [ 11 C]CFT PET when combined with [ 18 F]FDG PET for diagnosing early PD and differentiating PD from APS.

Methods

Totally 160 patients with suspected PD or APS underwent clinical assessment, SN‐TCS, and PET/CT. PET/CT images were evaluated by visual assessment based on predetermined disease‐specific patterns. Diagnoses of TCS‐SN were performed according to predefined criteria. Diagnostic performance was evaluated using 2 binary comparisons: PD versus non‐PD and APS versus non‐APS.

Results

After a median follow‐up period of 23 months, the final clinical diagnoses were PD (n = 72), APS (n = 50), and parkinsonian syndromes other than PD or APS (n = 33). For diagnosis of PD, combined SN‐TCS with [ 18 F]FDG PET/CT strategy exhibited comparable specificity to dual‐tracer PET/CT (90.4% vs. 95.2%, P = 0.344) but significantly lower sensitivity (34.7% vs. 84.7%, P < 0.001). Compared to TCS alone, the combined approach yielded similar sensitivity (34.7% vs. 36.1%, P = 1.000) and higher specificity (90.4% vs. 72.3%, P < 0.001). For APS diagnosis, this combined approach achieved comparable sensitivity (76.0% vs. 86.0%, P = 0.180), specificity (86.7% vs. 86.7%, P = 1.000), accuracy (83.2% vs. 86.5%, P = 0.302), and the area under the curve (0.81 vs. 0.86, P = 0.115) relative to dual‐tracer PET/CT.

Conclusion

The combination of SN‐TCS and [ 18 F]FDG PET/CT may serve as an effective triage tool for PD with high specificity. For APS, this combined strategy may provide a feasible diagnostic option in settings with limited access to dual‐tracer PET/CT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Substantia NigraPositron Emission Tomography Computed TomographyUltrasonography, Doppler, TranscranialParkinsonian DisordersParkinson DiseaseHumansFluorodeoxyglucose F18FemaleAgedMaleMiddle AgedRadiopharmaceuticalsDiagnosis, DifferentialDopaminergic ImagingAged, 80 and over

Stichwörter der Autor:innen

Parkinson's diseaseatypical parkinsonian syndromespositron emission tomographytranscranial sonography

Substanzen

Fluorodeoxyglucose F18Radiopharmaceuticals

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Daping Hospital, Army Medical University, Chongqing, China.
  • Department of Ultrasound, Daping Hospital, Army Medical University, Chongqing, China.
  • Chongqing Clinical Research Center for Imaging and Nuclear Medicine, Chongqing, China.

ORCID-Profile: Jingqin Fang, Xiao Chen

Förderung

  • AI Medical Research Project of Army Medical Center
  • Natural Science Foundation of Chongqing
  • Chongqing Science and Health Joint Medical Research Project
  • Science and Technology Innovation Ability Enhancement Project of Army Medical University
  • Natural Science Foundation of Chongqing Municipality

Zitieren

APA

Wu, T., Zhou, Z., Gong, W., Sun, J., Zhou, W., Li, X., Fang, J., & Chen, X. (2026). Combined Transcranial Sonography of the Substantia Nigra and 18 F‐Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Parkinson's Disease and Atypical Parkinsonian Syndromes. Movement Disorders Clinical Practice, 13(11), 2812-2821. https://doi.org/10.1002/mdc3.70769

Vancouver

Wu T, Zhou Z, Gong W, Sun J, Zhou W, Li X, et al. Combined Transcranial Sonography of the Substantia Nigra and 18 F‐Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Parkinson's Disease and Atypical Parkinsonian Syndromes. Movement Disorders Clinical Practice. 2026;13(11):2812-2821. doi:10.1002/mdc3.70769

BibTeX
@article{Wu2026,
  author = {Wu, Tong and Zhou, Ziwei and Gong, Wenjie and Sun, Jinju and Zhou, Weicheng and Li, Xin and Fang, Jingqin and Chen, Xiao},
  title = {Combined Transcranial Sonography of the Substantia Nigra and 18 F‐Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Parkinson's Disease and Atypical Parkinsonian Syndromes},
  journal = {Movement Disorders Clinical Practice},
  year = {2026},
  volume = {13},
  number = {11},
  pages = {2812--2821},
  doi = {10.1002/mdc3.70769}
}
Kostenlos starten →